Merck Buys Into Orna's Circular RNA Platform With Emphasis On Vaccines

 
• By Jessica Merrill
  
circles
Orna thinks circular RNA will present new drug therapeutics and vaccines • Source: Shutterstock

More from Deals

More from Business